IGF2BP2

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA035145

Antibody CAB017126

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most cancers showed moderate cytoplasmic immunoreactivity. A few cases of colorectal cancers and embryonal carcinomas were strongly stained. Lymphomas and most gliomas were weakly stained or negative.Moderate to strong cytoplasmic staining was observed in most cholangiocarcinomas, colorectal, skin, testicular, ovarian, gastric and pancreatic cancers and fracions of cases in most other cancers. Gliomas, lymphomas, renal, breast and prostate cancers were in general weakly stained or negative.

Validation

Uncertain: Two (or more) antibodies yielding dissimilar or partly similar staining patterns and there is no available gene/protein characterization data or only limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding dissimilar or partly similar staining patterns and there is no available gene/protein characterization data or only limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected